Indication:
U.S. FDA APPROVED DRUGS SURING 2022
Serial No 14
Name of the Drug- MUNJACO
Active Ingredient - Tirzepatide
Pharmacological Classification- To Inprove Blood sugar Control in Diabetes, in addition to Diet and Excercise
Date of Approval- 5/13/22